Advances in the use of nanomicelles to enhance the efficacy of antitumour substances (review)
Introduction. The influence of the dosage form on the pharmacological effect has been known since ancient times. The strategy for the preparation of micellar dosage forms for active antitumour substances was formulated in the last century. However, it has become widespread in practice in recent deca...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2025-06-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/2092 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849244630149758976 |
|---|---|
| author | E. V. Sanarova L. L. Nikolaeva S. D. Shceglov Zh. M. Kozlova O. L. Orlova N. A. Oborotova A. V. Lantsova |
| author_facet | E. V. Sanarova L. L. Nikolaeva S. D. Shceglov Zh. M. Kozlova O. L. Orlova N. A. Oborotova A. V. Lantsova |
| author_sort | E. V. Sanarova |
| collection | DOAJ |
| description | Introduction. The influence of the dosage form on the pharmacological effect has been known since ancient times. The strategy for the preparation of micellar dosage forms for active antitumour substances was formulated in the last century. However, it has become widespread in practice in recent decades. This is largely due to advances in the synthesis of new structural components for the formation of micellar carrier, as well as to the acquisition of better knowledge of biochemical processes occurring in the tumour cell.Text. This review is devoted to the achievements in the field of application of nanomicellar forms of antitumor drugs to improve the effectiveness of cancer therapy, which cover the period from 2019 to 2024. For this purpose, excipients used to obtain nanomicellar forms of antitumor substances are considered and analyzed, using docetaxel, paclitaxel, doxorubicin, and photosensitizers as examples. The creation of micellar forms allowed us to take a new look at these substances known in oncological practice.Conclusion. Available achievements in the field of nanomicelles application for increasing the effectiveness of antitumour substances undoubtedly show the promising development of this technological direction. However, there are still many unresolved issues related to the stability of nanomicelles when administered into the body, as well as legal regulation in the field of creation and introduction of this new pharmaceutical form. These questions still need to be resolved by pharmaceutical science. |
| format | Article |
| id | doaj-art-cc63a4d8cf3b440f9c498d8183ecd78e |
| institution | Kabale University |
| issn | 2305-2066 2658-5049 |
| language | Russian |
| publishDate | 2025-06-01 |
| publisher | LLC Center of Pharmaceutical Analytics (LLC «CPHA») |
| record_format | Article |
| series | Разработка и регистрация лекарственных средств |
| spelling | doaj-art-cc63a4d8cf3b440f9c498d8183ecd78e2025-08-20T03:59:04ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492025-06-0114213514710.33380/2305-2066-2025-14-2-20071359Advances in the use of nanomicelles to enhance the efficacy of antitumour substances (review)E. V. Sanarova0L. L. Nikolaeva1S. D. Shceglov2Zh. M. Kozlova3O. L. Orlova4N. A. Oborotova5A. V. Lantsova6Federal State Budgetary Institution "N. N. Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian FederationFederal State Budgetary Institution "N. N. Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation; I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)Federal State Budgetary Institution "N. N. Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation; I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)Federal State Budgetary Institution "N. N. Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian FederationFederal State Budgetary Institution "N. N. Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian FederationFederal State Budgetary Institution "N. N. Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian FederationIntroduction. The influence of the dosage form on the pharmacological effect has been known since ancient times. The strategy for the preparation of micellar dosage forms for active antitumour substances was formulated in the last century. However, it has become widespread in practice in recent decades. This is largely due to advances in the synthesis of new structural components for the formation of micellar carrier, as well as to the acquisition of better knowledge of biochemical processes occurring in the tumour cell.Text. This review is devoted to the achievements in the field of application of nanomicellar forms of antitumor drugs to improve the effectiveness of cancer therapy, which cover the period from 2019 to 2024. For this purpose, excipients used to obtain nanomicellar forms of antitumor substances are considered and analyzed, using docetaxel, paclitaxel, doxorubicin, and photosensitizers as examples. The creation of micellar forms allowed us to take a new look at these substances known in oncological practice.Conclusion. Available achievements in the field of nanomicelles application for increasing the effectiveness of antitumour substances undoubtedly show the promising development of this technological direction. However, there are still many unresolved issues related to the stability of nanomicelles when administered into the body, as well as legal regulation in the field of creation and introduction of this new pharmaceutical form. These questions still need to be resolved by pharmaceutical science.https://www.pharmjournal.ru/jour/article/view/2092nanomicellesantitumour substancespoloxamerstpgsantitumour activity |
| spellingShingle | E. V. Sanarova L. L. Nikolaeva S. D. Shceglov Zh. M. Kozlova O. L. Orlova N. A. Oborotova A. V. Lantsova Advances in the use of nanomicelles to enhance the efficacy of antitumour substances (review) Разработка и регистрация лекарственных средств nanomicelles antitumour substances poloxamers tpgs antitumour activity |
| title | Advances in the use of nanomicelles to enhance the efficacy of antitumour substances (review) |
| title_full | Advances in the use of nanomicelles to enhance the efficacy of antitumour substances (review) |
| title_fullStr | Advances in the use of nanomicelles to enhance the efficacy of antitumour substances (review) |
| title_full_unstemmed | Advances in the use of nanomicelles to enhance the efficacy of antitumour substances (review) |
| title_short | Advances in the use of nanomicelles to enhance the efficacy of antitumour substances (review) |
| title_sort | advances in the use of nanomicelles to enhance the efficacy of antitumour substances review |
| topic | nanomicelles antitumour substances poloxamers tpgs antitumour activity |
| url | https://www.pharmjournal.ru/jour/article/view/2092 |
| work_keys_str_mv | AT evsanarova advancesintheuseofnanomicellestoenhancetheefficacyofantitumoursubstancesreview AT llnikolaeva advancesintheuseofnanomicellestoenhancetheefficacyofantitumoursubstancesreview AT sdshceglov advancesintheuseofnanomicellestoenhancetheefficacyofantitumoursubstancesreview AT zhmkozlova advancesintheuseofnanomicellestoenhancetheefficacyofantitumoursubstancesreview AT olorlova advancesintheuseofnanomicellestoenhancetheefficacyofantitumoursubstancesreview AT naoborotova advancesintheuseofnanomicellestoenhancetheefficacyofantitumoursubstancesreview AT avlantsova advancesintheuseofnanomicellestoenhancetheefficacyofantitumoursubstancesreview |